iSpecimen Inc. Files Definitive Proxy Statement for 2024 Annual Meeting
Ticker: ISPC · Form: DEF 14A · Filed: Jun 10, 2024 · CIK: 1558569
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
Related Tickers: ISPC
TL;DR
iSpecimen (ISPC) proxy filed for July 19th meeting - vote on directors & governance.
AI Summary
iSpecimen Inc. filed its definitive proxy statement (DEF 14A) on June 10, 2024, for its annual meeting of stockholders scheduled for July 19, 2024. The filing outlines the agenda for the meeting, which includes the election of directors and other corporate governance matters. The company is based in Lexington, MA, and operates in the commercial physical & biological research sector.
Why It Matters
This filing provides shareholders with crucial information regarding the company's leadership, governance, and proposals to be voted on at the upcoming annual meeting, impacting their investment decisions.
Risk Assessment
Risk Level: medium — Proxy statements can reveal changes in leadership, strategic direction, or shareholder proposals that may impact the company's future performance and stock price.
Key Numbers
- 20240610 — Filing Date (Date the DEF 14A was filed with the SEC.)
- 20240719 — Meeting Date (Date of the shareholder meeting for which the proxy is being filed.)
Key Players & Entities
- iSpecimen Inc. (company) — Registrant
- June 10, 2024 (date) — Filing Date
- July 19, 2024 (date) — Annual Meeting Date
- Lexington, MA (location) — Company Headquarters
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information for the upcoming annual meeting on July 19, 2024, including details on director elections and other corporate governance matters.
When was this definitive proxy statement filed?
This definitive proxy statement was filed on June 10, 2024.
Where is iSpecimen Inc. headquartered?
iSpecimen Inc. is headquartered in Lexington, MA.
What is the Standard Industrial Classification for iSpecimen Inc.?
The Standard Industrial Classification for iSpecimen Inc. is SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731].
Is there a filing fee associated with this document?
No fee was required for this filing, as indicated by '[X] No fee required.'
Filing Stats: 4,820 words · 19 min read · ~16 pages · Grade level 11.7 · Accepted 2024-06-10 09:00:11
Key Financial Figures
- $0.0001 — nding shares of common stock, par value $0.0001 per share, at a ratio, ranging from one
- $13,500 — reed to pay Kingsdale Advisors a fee of $13,500 plus reimburse them for certain out-of-
Filing Documents
- tm242845-4_def14a.htm (DEF 14A) — 618KB
- lg_ispecimen-4c.jpg (GRAPHIC) — 14KB
- px_24ispecimenproxy2pg01-bw.jpg (GRAPHIC) — 248KB
- px_24ispecimenproxy2pg02-bw.jpg (GRAPHIC) — 184KB
- sg_tracycurley-bw.jpg (GRAPHIC) — 17KB
- 0001104659-24-069891.txt ( ) — 1197KB
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 26 Summary Compensation Table 26 Outstanding Equity Awards at Fiscal Year-End 26 Employment Agreements 27 TABLE OF CONTENTS Page Indemnification Agreements 29 Changes in Control 29 Compensation Committee Report 29 DIRECTOR COMPENSATION 30 Non-employee Director Compensation Table 30 Equity Incentive Plans 31
Security Ownership of Certain Beneficial Owners and Management and
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 35 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE 37 Policies and Procedures for Related Party Transactions 37 Employee, Officer and Director Hedging 37 Piggyback Registration Rights 37 Anti-Takeover Effects of Certain Provisions of Our Certificate of Incorporation and Bylaws 37 Choice of Forum 38 Indemnification of Directors and Officers 39 Transfer Agent 39 STOCKHOLDER PROPOSALS AND DIRECTOR NOMINATIONS FOR THE 2025 ANNUAL MEETING 40 HOUSEHOLDING 40 2023 ANNUAL REPORT 40 Annex A—Amendment to the Fourth Amended and Restated Certificate of Incorporation A-1 Annex B—Proxy Card TABLE OF CONTENTS iSpecimen Inc. 450 Bedford Street Lexington, MA 02420 PROXY STATEMENT FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JULY 19, 2024 This proxy statement (the "Proxy Statement") and our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the "2023 Annual Report" and, together with the Proxy Statement, the "proxy materials") are being furnished by and on behalf of the board of directors (the "Board" or the "Board of Directors") of iSpecimen Inc. (the "Company," "Corporation," "iSpecimen," "we," "us," or "our"), in connection with our 2024 annual meeting of stockholders (the "Annual Meeting"). This Notice of Annual Meeting. Proxy Statement and 2023 Annual Report are first being distributed or made available, as the case may be, on or about June 10, 2024. GENERAL INFORMATION ABOUT THE ANNUAL MEETING AND VOTING QUESTIONS AND ANSWERS Why am I receiving these proxy materials? You are receiving this Proxy Statement and proxy card from the Company because, at the close of business on June 3, 2024 ("the Record Date"), you were a holder of record of shares of common stock of the Company. This Proxy Statement describes the matters that will be presented for your con